Therapix stock: buy or sell?

TRPX stock price: $1.34 0.00% At close on December 6th, 2019

Updated on:
December 6th, 2019

0

Therapix closed today at $1.34 and stayed stable a neutral 0.00%. On Tuesday TRPX collapsed a chilling -9.30%. Friday was the 3rd green day in a row, soaring 3.55%.

Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules.

Should I buy Therapix stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Having a trading strategy helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

Currently, Therapix stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Therapix stock a buy?

Banks and financial institutions publish stock ratings everyday. Unfortunately, we couldn't find any rating for TRPX stock for the last month.

Therapix stock analysis

Daily outlook

Therapix shares stayed steady 0.00% to $1.34 today.

Therapix shares stayed constant 0.00% to $1.34 today.

TRPX stock chart (daily)

Weekly outlook

Therapix Biosciences plummed a hair-raising -15.19% this week. By mid October TRPX rocketed an outstanding 12.64% in just one week.

Since price and 40-weeks moving average lines crossed down by mid March, TRPX fell $-3.21 per share (-70.55%). Trading stocks that are below the 40-weeks (that is, 200-days) moving average line is not recommended by many experts, as it indicates that the stock has not enough institutional support.

TRPX stock chart (weekly)

Therapix stock price history

Therapix stock went public on March 22nd, 2017 with a price of $6.301. Since then, TRPX stock sliced a -78.70%, with a yearly average of -39.40%.

1: Adjusted price after possible price splits or reverse-splits.

Therapix stock historical price chart

TRPX stock reached 52-week highs at $5.64, and all-time highs 2017-03-23 with a price of 10.95.

Therapix stock price target

How much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last 30 days we have not found any price target for Therapix stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

After posting its last earnings report , Therapix . Unfortunately, reported EPS is not yet available in our database.
TRPX earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2016-Q4-n/an/an/a
2017-Q1-n/an/an/a
2017-Q2-n/an/an/a
2017-Q3-n/an/an/a
2017-Q42018-04-30n/a0.83n/a
2018-Q12018-05-31n/a0.59n/a
2018-Q22018-08-20n/a-0.35n/a
2018-Q32018-12-03n/a-0.5n/a
2018-Q4-n/an/an/a
2019-Q1-n/an/an/a

Annual financial results

Compared to , last anual revenues report draw of to M dollars. When comparing vs , , profit margin (that is, the net income divided by revenues) a to .

TRPX annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY

Quarterly financial results

Reported quarter income marked $-1.74 million with a profit margin of . Profit margin remained stable a 0.00% compared to previous quarter when profit margin was inf%. When comparing sales to same quarter last year, Therapix Biosciences sales marked a neutral movement and stayed steady a nan%. Looking back to recent quarterly results, Therapix posted 5 positive quarters in a row.
TRPX quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2

Therapix ownership

When you are planning to buy a company, it's worth to review its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Therapix, 2.08% of all outstanding shares are owned by its staff.

In case of Therapix Biosciences stock, 0.00% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for TRPX stock account 0.00%, no big difference from last month.

For a better context understanding, the following table shows ownership data compared to other related stocks:

TRPX
Market cap$5.9 M
Total shares4.4 M
Float shares4.0 M
  - Institutional holdings (%)0.0%
  - Insider holdings (%)2.1%
Shares in short selling0.0%

Therapix summary

Friday, December 6th, 2019
Open$1.35
Close$1.34
Day range$1.31 - $1.39
Previous close$1.34
Session gain0.00%
Average true range$0.20
50d mov avg$2.09
100d mov avg$2.32
200d mov avg$2.82
Daily pattern
Weekly pattern lb06a

Therapix performance

To better understand Therapix Biosciences performance you must compare its gains with other related stocks in same sector or industry. We compared Therapix Biosciences against in the following table:
Stock3m6m12m
TRPXTherapix Bioscien...-49.24%-50.92%-74.48%

Therapix competitors

Unfortunately, we could not find any public company that could be defined as Therapix competitor. This doesn't mean Therapix does not have any competitor in the market, it's just we could not detected it.